Results 131 to 140 of about 16,504,620 (285)

The Evolving Role of Pharmacists in Home Medication Review: A Scoping Review

open access: yesJournal of Pharmacy
Introduction: Irrational and inappropriate medication use remains a major global challenge. Home Medication Review (HMR) is a patient-centred service in which pharmacists conduct structured medication assessments in patients’ homes to identify drug ...
Muhammad Jawad Hassan   +5 more
doaj   +1 more source

Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation

open access: yesMolecular Oncology, EarlyView.
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu   +9 more
wiley   +1 more source

Understanding the Socioeconomic and Geographical Characteristics of Beneficiaries Receiving a Comprehensive Medication Review. [PDF]

open access: yesJ Manag Care Spec Pharm, 2020
Chou J   +6 more
europepmc   +1 more source

Self-efficacy for medication management: a systematic review of instruments

open access: yes, 2018
Larkin Lamarche, Ambika Tejpal, Dee Mangin Department of Family Medicine, McMaster University, Hamilton, ON, Canada Background: Medication self-efficacy is a potentially important construct in research around optimal use of prescription medications.
Tejpal A, Lamarche L, Mangin D
core  

Unique circulating miRNAome signatures captured with distinct molecular states in Lynch syndrome and sporadic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso   +5 more
wiley   +1 more source

Clinical practice of medication reconciliation services in glaucoma patients

open access: yesYanke Xuebao
[Objective:] To introduce medication reconciliation (MR) services for glaucoma patients, with the aim of delivering safe, effective, and cost-effective pharmaceutical care.
CHEN Xin, HUANG Ying
doaj   +1 more source

Medication Review and Medication Reconciliation

open access: yes, 2018
Medication review and medication reconciliation are systematic processes with the aim of increasing patient safety as well as effectiveness and efficiency on different levels.
Schulz, Martin   +7 more
core   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Postpartum Hemorrhage: A Comprehensive Review of Medical and Surgical Treatment

open access: yesMaternal-Fetal Medicine
Abstract Postpartum hemorrhage (PPH) is the leading cause of maternal morbidity and mortality worldwide. The incidence of PPH continues to rise. PPH is often responsive to both medical and surgical treatment.
Cox, Avery Lin, Shainker, Scott A.
openaire   +2 more sources

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy